Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Long-Term Investments (2020 - 2025)

Historic Long-Term Investments for Amphastar Pharmaceuticals (AMPH) over the last 6 years, with Q3 2025 value amounting to $13.3 million.

  • Amphastar Pharmaceuticals' Long-Term Investments rose 4148.94% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year increase of 4148.94%. This contributed to the annual value of $11.0 million for FY2024, which is 2512.09% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Long-Term Investments stood at $13.3 million for Q3 2025, which was up 4148.94% from $12.1 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Long-Term Investments high stood at $15.2 million for Q1 2024, and its period low was $2.0 million during Q1 2021.
  • For the 5-year period, Amphastar Pharmaceuticals' Long-Term Investments averaged around $7.3 million, with its median value being $5.4 million (2023).
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Long-Term Investments soared by 90000.0% in 2021 and then tumbled by 3009.3% in 2025.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Long-Term Investments stood at $4.0 million in 2021, then increased by 12.92% to $4.5 million in 2022, then skyrocketed by 226.33% to $14.7 million in 2023, then decreased by 25.12% to $11.0 million in 2024, then grew by 20.95% to $13.3 million in 2025.
  • Its Long-Term Investments stands at $13.3 million for Q3 2025, versus $12.1 million for Q2 2025 and $10.6 million for Q1 2025.